SUSCEPTIBILITY T O I N V ITRO T OLERANCE I NDUCTION OF A DULT B CELLS F ROM MICE W ITH A N X -LINKED B -CELL D EFECT*

CBA/N mice, a mutant subline of the CBA/Ca strain, have an X-linked B lymphocyte-immun e defect. These mice and F1 male progeny derived from CBA/N females fail to produce specific antibody after immunization with certain thymicindependent (TI) antigens (1-4). In addition, these mice fail to produce IgM or IgG responses to either the TI or T-dependent derivatives of the hapten phosphorylcholin e (PC) (5, 6). Moreover, analysis of surface membrane characteristics indicates that B cells derived from immune defective mice fail to express determinants that are present on a population of B lymphocytes that appears late in ontogeny. These include minor lymphocyte-stimu lating determinants (7), Lyb5 (8), and Lyb3 (9). Furthermore, the B cells of CBA/N mice have unusually high amounts of surface IgM (sIgM) and exhibit a low ratio of surface 8:/~ heavy chains when compared with the B cells of normal mice (10, 11). These surface characteristics are similar to those that are exhibited by neonatal B cells (10). Taken together, these findings are consistent with the hypothesis that the immune defect(s) in CBA/N mice arise from a maturational arrest either in the development of CBA/N B cells or of a subpopulation of these B

[1]  E. Metcalf,et al.  Murine Models of Tolerance Induction in Developing and Mature B Cells , 1979, Immunological reviews.

[2]  J. Quintáns,et al.  Failure of CBA/N mice to respond to thymus-dependent and thymus-independent phosphorylcholine antigens. , 1978, Cellular immunology.

[3]  W. Paul,et al.  Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers , 1977, The Journal of experimental medicine.

[4]  E. Metcalf,et al.  In vitro tolerance induction of bone marrow cells: a marker for B cell maturation. , 1977, Journal of immunology.

[5]  H. Cantor,et al.  Identification of a B-cell surface structure involved in antigen- dependent triggering: absence of this structure on B cells from CBA/N mutant mice , 1977, The Journal of experimental medicine.

[6]  A. Ahmed,et al.  B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens , 1977, The Journal of experimental medicine.

[7]  A. Ahmed,et al.  Studies on non-H-2-linked lymphocyte-activating determinants. II. Nonexpression of Mls determinants in a mouse strain with an X-linked B lymphocyte immune defect. , 1976, Journal of immunology.

[8]  W. Paul,et al.  X-linked B-lymphocyte defect in CBA/N mice. III. Abnormal development of B-lymphocyte populations defined by their density of surface immunoglobulin , 1976, The Journal of experimental medicine.

[9]  E. Metcalf,et al.  In vitro tolerance induction of neonatal murine B cells. , 1976, The Journal of experimental medicine.

[10]  D. Mosier,et al.  In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice. , 1976, Journal of immunology.

[11]  W. Paul,et al.  Abnormal ratio of membrane immunoglobulin classes in mice with an X- linked B-lymphocyte defect , 1975, The Journal of experimental medicine.

[12]  W. Paul,et al.  X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect , 1975, The Journal of experimental medicine.

[13]  N. Klinman,et al.  The characterization fo the B-cell repertoire specific for the 2,4- dinitrophenyl and 2,4,6-trinitrophenyl determinants in neonatal BALB/c mice , 1975, The Journal of experimental medicine.

[14]  A. Steinberg,et al.  The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain. , 1973, Journal of immunology.

[15]  P. Baker,et al.  GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE , 1972, The Journal of experimental medicine.